Elicio Therapeutics Activates Phase 1 Study of ELI-002 7P
Boston, Aug. 10, 2026 Elicio Therapeutics, Inc. announced the activation of an investigator-initiated Phase 1 clinical study evaluating its...
Maternal Health
Advertisement
Telomir Pharmaceuticals Publishes Telomir-Zn Cancer Data
Miami, August 10, 2026 Telomir Pharmaceuticals, Inc. announced the peer-reviewed publication of preclinical data showing that Telomir-Zn suppressed tumor...
Revvity Launches SuperFlex Prenatal Screening System
Waltham, Mass., August 10, 2026 Revvity, Inc. announced the launch of its SuperFlex™ prenatal screening system, a compact, CE-IVDR...
IMNN-001 Demonstrates Clinical Promise in Advanced Ovarian Cancer
LAWRENCEVILLE, N.J., July 21, 2026 IMUNON, Inc. has announced positive preliminary Phase 2 minimal residual disease (MRD) clinical data...
Myriad Launches FirstGene for Earlier Prenatal Genetic Screening
SALT LAKE CITY, Utah, July 21, 2026 Myriad Genetics has officially launched the FirstGene® Multiple Prenatal Screen, introducing what...
Advertisements
Denali Therapeutics Showcases BBB Innovation at AAIC 2026
SOUTH SAN FRANCISCO, Calif. | July 9, 2026 Denali Therapeutics has announced that co-founder and Chief Executive Officer Ryan...
Sera Prognostics Reports Positive PRIME Trial Results
SALT LAKE CITY | July 9, 2026 Sera Prognostics Inc., a leader in precision pregnancy diagnostics, has announced the...
Sera Applauds Illinois Medicaid Coverage for PreTRM Blood Test
SALT LAKE CITY, June 23, 2026 Sera Prognostics Inc. welcomed new legislative action in Illinois that expands Medicaid coverage...
Osel Launches Phase 2b Trial for Preterm Birth Prevention
MOUNTAIN VIEW, Calif., ARLINGTON, Va., and LONDON, England, May 13, 2026 Osel Inc., in partnership with March of Dimes...
FDA Releases Pregnancy Safety Guidance for Drugs and Biologics
WASHINGTON, D.C., United States – May 8, 2026 The U.S. Food and Drug Administration announced the release of a...
Advertisement
